Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 21, 2022

BUY
$72.62 - $79.98 $196,945 - $216,905
2,712 New
2,712 $209,000
Q4 2018

Jan 25, 2019

SELL
$48.76 - $63.23 $49,345 - $63,988
-1,012 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $55,852 - $62,997
1,012 New
1,012 $63,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mountain Pacific Investment Advisers Inc Portfolio

Follow Mountain Pacific Investment Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mountain Pacific Investment Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mountain Pacific Investment Advisers Inc with notifications on news.